Skip to main content
. 2012 Oct 1;5(5):344–355. doi: 10.1593/tlo.12190

Table 2.

Effect of L + E + P on Cancer-Related miRNAs.

miRNA Function Fold Change Targets
miR144 Tumor-suppressive →772941-fold Notch-1
miR-133b Tumor-suppressive →177812-fold c-MET, FSCN1
miR-1 Tumor-suppressive →66913-fold Cyclin D2, CXCR4, SDF1α
miR-122 Proapoptotic →9741-fold Cyclin B1
miR-34c Tumor-suppressive →6700-fold E2F3, Bcl2, c-MET
miR-200c Tumor-suppressive →5077-fold ZEB1, ZEB2, FN1, MSN
miR-127 Tumor-suppressive →4067-fold E2F3, Notch-1, Bcl2
miR-335 Tumor-suppressive →3983-fold COLA1, SOX4, TNC
miR-124 Tumor-suppressive →1389-fold ROCK2, EZH2, CDK6
miR-181a Tumor-suppressive →962-fold K-ras, Bcl2
miR-7 Tumor-suppressive →849-fold Bcl2, EGFR, IGF1R
miR-215 Tumor-suppressive →820-fold DTL
miR-15a Tumor-suppressive →786-fold Fgf2, cyclin E2
Let-7d Tumor-suppressive →4-fold Twist
miR-20a Oncogenic ↓13587-fold APP
miR-21 Oncogenic ↓1260-fold TMP1, Pdcd4, MARCKS
miR-9 Oncogenic ↓173-fold E-cadherin
miR-29b Oncogenic ↓48-fold PTEN
miR-181b Oncogenic ↓39-fold PTEN, TIMP3

Effects of PJ on the levels of metastasis-related miRNAs. RNA from PC3 cells treated with L + E + P at 8 µg/ml for 12 hours was submitted to miRNA PCR array analysis. Relative miRNA levels are shown as fold change compared with untreated control.